5IN - TIGIT immunotherapy

Date	05 March 2018
Event	TAT 2018 - Targeted Anticancer Therapies
Session	Novel immuno targets
Presenter	Hassane M. Zarour
Authors	H.M. Zarour Author Affiliations -, University of Pittsburgh Cancer Institute, 15232 - Pittsburgh/US

Scroll

OncologyPRO satisfaction rate is 96% from the result of a June 2018 online survey

Daily News

ESMO Videos

What's new on OncologyPRO?

OncologyPRO structure explained

Clinical Practice Guidelines

Pocket Guidelines & Mobile App

ESMO Consensus Conferences

Practice Tools

Anti-Cancer Agents and Biological Therapy

Bioethics, legal and economic issues

Cancer Aetiology, Epidemiology and Prevention

Cancer Immunology and Immunotherapy

Cancer in Special situations (pregnancy, young, elderly, hereditary...)

Imaging, Diagnosis and Staging

Palliative and Supportive care

Pathology and Molecular Biology

Personalised Medicine

Surgery and / or Radiotherapy

Translational Research: Biomarkers & Diagnostics

Rare Cancers

Resources for Patients

Discover ESMO journals

Essentials for Clinicians

Handbooks

ESMO E-Learning and V-Learning

Factsheets on Anti-Cancer Agents

Factsheets on Biomarkers

Clinical Trial Resources

Educational Slides

Glossary of Molecular Biology

Glossary of Precision Medicine

Cancer in Medical Journals

User’s Manual for Oncology Clinicians

Abbreviations

Links to Cancer Journals

Global Curriculum in Medical Oncology

Scientific Meeting Reports

Slide Resources

Breast Cancer

Carcinoma of Unknown Primary Site

Central Nervous System Malignancies

Endocrine Cancers

Gastrointestinal Cancers

Genitourinary Cancers

Gynaecological Malignancies

Haematological Malignancies

Head and Neck Cancers

Lung and other Thoracic Tumours

Melanoma and other Skin Tumours

Sarcomas

5IN - TIGIT immunotherapy